Skip to content

Survey on postprandial hyperglycemia in patients with type 2 diabetes

Survey on postprandial hyperglycemia in patients with type 2 diabetes - Survey on postprandial hyperglycemia in patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036531
Enrollment
1000
Registered
2019-04-19
Start date
2019-04-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

None listed

Sponsors

Qlife CO.,LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes Patients who regularly go to medical institutions for treatment of type 2 diabetes

Exclusion criteria

Exclusion criteria: No specific criteria

Design outcomes

Primary

MeasureTime frame
Recognition of postprandial hyperglycemia, expectations for treatment

Secondary

MeasureTime frame
Treatment of diabetes Influence on daily life Communication with medical staff Recognition and treatment of postprandial hyperglycemia Expectations for postprandial hyperglycemia treatment

Countries

Japan

Contacts

Public ContactYuriko Kitahara

QLife Co., Ltd. Medical Solution

y-kitahara@qlife.co.jp03-6860-5020

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026